YTHDF2 Inhibitors

YTHDF2 inhibitors as a chemical class are compounds that interface with the cellular machinery governing RNA methylation patterns, particularly the m^6A modification on RNA. This interface can occur through direct competition at the recognition site of YTHDF2 or by altering the substrate availability, enzyme activity, or expression levels within the m^6A pathway. The activity of such inhibitors encompasses a range of biochemical interactions. It includes competing analogs that mimic the m^6A structure, such as 7-Methylguanosine, and extends to compounds that can alter the levels of global or gene-specific m^6A modifications, like S-Adenosylmethionine or its cycle inhibitors. This can result in changes in the binding efficiency of YTHDF2 to its target mRNAs, thereby modulating its functional output.

Furthermore, by influencing the expression of enzymes involved in m^6A deposition or removal, or by impacting the availability of methylation donors, such inhibitors indirectly modulate the activity of YTHDF2. Some compounds achieve this by targeting DNA or histone methylation, like RG108 or BIX-01294, thereby exerting a more upstream effect on gene expression patterns, including those coding for components of the m^6A machinery. The overarching impact of these molecules lies in the alteration of cellular methylome and, subsequently, the transcriptome, which in turn influences the RNA decay processes governed by YTHDF2.